LV11429A - Triciklopoliazamakrociklofosfonskabes to kompleksi un atvasinajumi izmantosanai par kontrastvielam - Google Patents

Triciklopoliazamakrociklofosfonskabes to kompleksi un atvasinajumi izmantosanai par kontrastvielam

Info

Publication number
LV11429A
LV11429A LV950361A LV950361A LV11429A LV 11429 A LV11429 A LV 11429A LV 950361 A LV950361 A LV 950361A LV 950361 A LV950361 A LV 950361A LV 11429 A LV11429 A LV 11429A
Authority
LV
Latvia
Prior art keywords
complexes
derivatives
tricyclopiazamacrocyclophosphonates
contrast media
cyclopolyazamacrocyclophosphonic
Prior art date
Application number
LV950361A
Other languages
English (en)
Other versions
LV11429B (en
Inventor
Garry E Kiefer
Original Assignee
Dow Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Chemical Co filed Critical Dow Chemical Co
Publication of LV11429A publication Critical patent/LV11429A/lv
Publication of LV11429B publication Critical patent/LV11429B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/18—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed systems contains four or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00—Arrangements or instruments for measuring magnetic variables
    • G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/28—Details of apparatus provided for in groups G01R33/44 - G01R33/64
    • G01R33/281—Means for the use of in vitro contrast agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • General Physics & Mathematics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Luminescent Compositions (AREA)
LVP-95-361A 1993-05-06 1995-12-06 Tricyclopolyazamacrocyclophosphonic acids, complexes and derivates thereof, for use as contrast agents LV11429B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/058,622 US5385893A (en) 1993-05-06 1993-05-06 Tricyclopolyazamacrocyclophosphonic acids, complexes and derivatives thereof, for use as contrast agents
PCT/US1994/005071 WO1994026276A1 (en) 1993-05-06 1994-05-06 Tricyclopolyazamacrocyclophosphonic acids, complexes and derivatives thereof, for use as contrast agents

Publications (2)

Publication Number Publication Date
LV11429A true LV11429A (lv) 1996-08-20
LV11429B LV11429B (en) 1997-04-20

Family

ID=22017946

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-95-361A LV11429B (en) 1993-05-06 1995-12-06 Tricyclopolyazamacrocyclophosphonic acids, complexes and derivates thereof, for use as contrast agents

Country Status (17)

Country Link
US (1) US5385893A (lv)
EP (1) EP0697872B1 (lv)
JP (1) JP3553940B2 (lv)
KR (1) KR960702462A (lv)
CN (1) CN1125906A (lv)
AT (1) ATE316377T1 (lv)
AU (1) AU687400B2 (lv)
BG (1) BG100194A (lv)
CA (1) CA2162172A1 (lv)
DE (1) DE69434618T2 (lv)
FI (1) FI955336A (lv)
HU (1) HUT72649A (lv)
LV (1) LV11429B (lv)
NO (1) NO954441L (lv)
PL (1) PL311649A1 (lv)
SG (1) SG46496A1 (lv)
WO (1) WO1994026276A1 (lv)

Families Citing this family (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5645818A (en) * 1989-03-24 1997-07-08 Guerbet S.A. Diagnostic compositions comprising a complex formed by a nitrogenous macrocyclic ligand with metal ions
US5739294A (en) * 1991-12-10 1998-04-14 The Dow Chemical Company Bicyclopol yazamacrocyclophosphonic acid complexes for use as contrast agents
US5714604A (en) * 1993-05-06 1998-02-03 The Dow Chemical Company Process for the preparation of azamacrocyclic or acyclic aminophosphonate ester derivatives
US5672335A (en) * 1994-11-30 1997-09-30 Schering Aktiengesellschaft Use of metal complexes as liver and gallbladder X-ray diagnostic agents
US6207826B1 (en) * 1995-03-27 2001-03-27 Isis Pharmaceuticals, Inc. Macrocyclic compounds having nitrogen-containing linkages
EP0817787A4 (en) * 1995-03-27 2000-09-13 Isis Pharmaceuticals Inc NITROGEN MACROCYCLIC COMPOUNDS
DE19546234C1 (de) * 1995-12-04 1997-08-28 Schering Ag Neue makrobicyclische Verbindungen, Verfahren zu ihrer Herstellung und diese makrobicyclischen Verbindungen enthaltende pharmazeutische Mittel
US5834456A (en) * 1996-02-23 1998-11-10 The Dow Chemical Company Polyazamacrocyclofluoromonoalkylphosphonic acids, and their complexes, for use as contrast agents
CA2251924C (en) * 1996-04-19 2006-05-30 The Dow Chemical Company Fluorescent chelates as visual tissue specific imaging agents
BR9911248A (pt) 1998-06-15 2001-03-13 Unilever Nv Ligando macrocìclico, complexo, catalisador de branqueamento, composição, e, processo de branquear e/ou limpar um substrato.
AU1092601A (en) * 1999-10-18 2001-04-30 Dow Global Technologies Inc. Aminoalkylenephosphonates for treatment of bone disorders
US6794371B1 (en) * 1999-10-18 2004-09-21 The Dow Chemical Company Aminoalkylenephosphonates for treatment of bone disorders
EP1778699A4 (en) * 2004-08-10 2009-02-25 Dow Global Technologies Inc TARGETING OF CHELANTS AND CHELATES
US20100111856A1 (en) 2004-09-23 2010-05-06 Herman Gill Zirconium-radiolabeled, cysteine engineered antibody conjugates
CA2580141C (en) 2004-09-23 2013-12-10 Genentech, Inc. Cysteine engineered antibodies and conjugates
WO2007140371A2 (en) 2006-05-30 2007-12-06 Genentech, Inc. Antibodies and immunoconjugates and uses therefor
RU2639543C9 (ru) 2006-10-27 2018-06-14 Дженентек, Инк. Антитела и иммуноконъюгаты и их применения
AR065271A1 (es) 2007-02-09 2009-05-27 Genentech Inc Anticuerpos anti-robo4 y sus usos
ES2579323T3 (es) 2007-07-16 2016-08-09 Genentech, Inc. Anticuerpos anti-CD79B e inmunoconjugados y métodos de uso
AU2008276128B2 (en) 2007-07-16 2013-10-10 Genentech, Inc. Humanized anti-CD79b antibodies and immunoconjugates and methods of use
CL2009000062A1 (es) 2008-01-31 2010-05-14 Genentech Inc Anticuerpo humanizado anti cd79b; con modificaciones de cisterna libre; inmunoconjugado que contiene dicho anticuerpo y una droga; polinucleotido que codifica el anticuerpo; vector, celula huesped; composicion farmaceutica y uso de dicha composicion para tratar cancer, preferentemente linfomas.
PE20120878A1 (es) 2009-04-01 2012-08-06 Genentech Inc ANTICUERPOS ANTI-FcRH5 E INMUNOCONJUGADOS
PL2896404T3 (pl) 2009-06-04 2017-12-29 Novartis Ag Sposoby identyfikacji miejsc koniugacji IgG
US9012630B2 (en) * 2009-09-18 2015-04-21 Clariant International Ltd. Method for producing bridged manganese complexes of triazacyclononane
RU2580038C2 (ru) 2009-12-04 2016-04-10 Дженентек, Инк. Мультиспецифические антитела, аналоги антител, композиции и способы
EP2577310B1 (en) 2010-06-03 2018-11-14 F.Hoffmann-La Roche Ag Immuno-pet imaging of antibodies and immunoconjugates and uses therefor
RU2626537C2 (ru) 2010-06-08 2017-07-28 Дженентек, Инк. Полученные с помощью генной инженерии антитела с цистеиновыми заменами и их конъюгаты
WO2014006124A1 (en) 2012-07-04 2014-01-09 F. Hoffmann-La Roche Ag Covalently linked antigen-antibody conjugates
EP3339328A1 (en) 2012-07-04 2018-06-27 F. Hoffmann-La Roche AG Anti-biotin antibodies and methods of use
MX353951B (es) 2012-07-04 2018-02-07 Hoffmann La Roche Anticuerpos de anti-teofilina y metodos de uso.
BR112016014945A2 (pt) 2014-01-03 2018-01-23 F. Hoffmann-La Roche Ag conjugado, formulação farmacêutica e uso
CA2933384A1 (en) 2014-01-03 2015-07-09 F. Hoffmann-La Roche Ag Bispecific anti-hapten/anti-blood brain barrier receptor antibodies, complexes thereof and their use as blood brain barrier shuttles
CA2930154A1 (en) 2014-01-03 2015-07-09 F. Hoffmann-La Roche Ag Covalently linked helicar-anti-helicar antibody conjugates and uses thereof
KR20170052600A (ko) 2014-09-12 2017-05-12 제넨테크, 인크. 시스테인 가공된 항체 및 콘주게이트
JP6618539B2 (ja) 2014-12-17 2019-12-11 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ ソルターゼを使用した酵素媒介性のポリペプチドコンジュゲーションのための方法
EP3353201B1 (en) 2015-09-25 2021-09-08 F. Hoffmann-La Roche AG Recombinant immunoglobulin heavy chains comprising a sortase conjugation loop and conjugates thereof
WO2017050866A1 (en) 2015-09-25 2017-03-30 F. Hoffmann-La Roche Ag Novel soluble sortase a
EP3353314A1 (en) 2015-09-25 2018-08-01 H. Hoffnabb-La Roche Ag Transamidation employing sortase a in deep eutectic solvents
JP6895953B2 (ja) 2015-09-25 2021-06-30 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ ソルターゼａを利用してチオエステルを作製するための方法
WO2017089847A1 (en) 2015-11-26 2017-06-01 Debreceni Egyetem New 3,6,9, 15-tetraaza-bicyclo [9.3.1 ]pentadeca- 1(14), 11(15), 12-triene based compounds and their application as ligands of essential metal ion based mri and 52mn based pet contrast agents
WO2017089848A1 (en) * 2015-11-26 2017-06-01 Debreceni Egyetem New 2, 1 l -diaza-[3.3](2,6)pyridinophane compounds and their application as ligands of essential metal ion based mri contrast agents and 52mn based pet contrast agents
US10494379B2 (en) 2015-11-26 2019-12-03 Debreceni Egyetem 6-oxa-3,9,15-triaza-bicyclo[9.3.1]pentadeca-1(14),11(15),12-triene derivatives based compounds and their application as ligands of essential metal ion based MRI and 52MN based PET contrast agents
FR3045053B1 (fr) * 2015-12-09 2018-01-05 Cisbio Bioassays Agents complexants hydrosolubles a base de triazapyridinophane et complexes de lanthanide fluorescents correspondants
WO2017167712A1 (en) 2016-03-30 2017-10-05 F. Hoffmann-La Roche Ag Improved sortase
KR102495650B1 (ko) 2017-04-12 2023-02-02 에프. 호프만-라 로슈 아게 알데히드 함유 표적 분자의 라벨링 방법
EP3652214A1 (en) 2017-07-13 2020-05-20 H. Hoffnabb-La Roche Ag New binding agent and assay for pivka
JP7403444B2 (ja) 2017-10-20 2023-12-22 エフ． ホフマン－ラ ロシュ アーゲー 抗体の複写保護措置
EP3717517A1 (en) 2017-11-30 2020-10-07 H. Hoffnabb-La Roche Ag Anti-pd-l1 antibodies and methods of using the same for detection of pd-l1
CN111971300A (zh) 2018-03-14 2020-11-20 豪夫迈·罗氏有限公司 新颖的抗-肌钙蛋白t抗体
WO2019175131A1 (en) 2018-03-14 2019-09-19 F. Hoffmann-La Roche Ag Method for affinity maturation of antibodies
EP3781600A1 (en) 2018-04-18 2021-02-24 F. Hoffmann-La Roche AG Novel anti-thymidine kinase antibodies
EP3844503B1 (en) 2018-08-31 2024-05-29 F. Hoffmann-La Roche AG Thymidine kinase (tk-1) in prognostic indices for dlbcl
US20220001043A1 (en) 2018-09-28 2022-01-06 Imaginab, Inc. Cd8 imaging constructs and methods of use thereof
BR112022000172A2 (pt) 2019-07-22 2022-02-22 Hoffmann La Roche Métodos para avaliar se uma paciente tem endometriose, para selecionar uma paciente para terapia e para monitorar uma paciente
WO2021013781A1 (en) 2019-07-22 2021-01-28 F. Hoffmann-La Roche Ag Substance p as blood biomarker for the non-invasive diagnosis of endometriosis
BR112022001140A2 (pt) 2019-07-22 2022-03-15 Hoffmann La Roche Métodos para avaliar se um paciente tem endometriose ou está em risco de desenvolver endometriose, selecionar um paciente para terapia e monitorar um paciente que sofre de endometriose ou que está sendo tratado para endometriose
WO2021013786A1 (en) 2019-07-22 2021-01-28 F. Hoffmann-La Roche Ag S100a6 as blood biomarker for the non-invasive diagnosis of endometriosis
KR20220024782A (ko) 2019-07-22 2022-03-03 에프. 호프만-라 로슈 아게 자궁내막증의 비침습적 진단을 위한 혈액 바이오마커로서의 s100a8
JP2023502360A (ja) 2019-11-15 2023-01-24 エフ．ホフマン－ラ ロシュ アーゲー 患者試料における質量分析測定のためのβ－ラクタム抗生物質の誘導体化
KR20230092930A (ko) 2020-10-30 2023-06-26 에프. 호프만-라 로슈 아게 담관암종의 표지자로서의 timp1
US20230406909A1 (en) 2020-11-02 2023-12-21 Roche Diagnostics Operations, Inc. Sars-cov-2 nucleocapsid antibodies
WO2022207628A1 (en) 2021-03-30 2022-10-06 F. Hoffmann-La Roche Ag Scf as blood biomarker for the non-invasive diagnosis of endometriosis
EP4314838A1 (en) 2021-04-01 2024-02-07 F. Hoffmann-La Roche AG Psp94 as blood biomarker for the non-invasive diagnosis of endometriosis
EP4341700A1 (en) 2021-05-17 2024-03-27 F. Hoffmann-La Roche AG Sfrp4 as blood biomarker for the non-invasive diagnosis of adenomyosis
CN118434762A (zh) 2021-10-26 2024-08-02 豪夫迈·罗氏有限公司 对SARS-CoV-2 RBD具有特异性的单克隆抗体
CN118382636A (zh) 2021-12-17 2024-07-23 豪夫迈·罗氏有限公司 一种用于检测淀粉样蛋白β42(Aβ42)的新抗体
WO2023131594A1 (en) 2022-01-05 2023-07-13 F. Hoffmann-La Roche Ag Derivatization of compounds in patient samples for therapeutic drug monitoring (tdm)
WO2023247752A1 (en) 2022-06-23 2023-12-28 F. Hoffmann-La Roche Ag Method for diagnosing endometriosis and for classifying the stage of endometriosis
WO2024017983A1 (en) 2022-07-22 2024-01-25 F. Hoffmann-La Roche Ag Meteorin-like protein (metrnl) as (blood) biomarker for the diagnosis of polycystic ovarian syndrome
WO2024017985A1 (en) 2022-07-22 2024-01-25 F. Hoffmann-La Roche Ag Fibroblast growth factor binding protein 1 (fgfbp1) as (blood) biomarker for the diagnosis of polycystic ovarian syndrome
WO2024017982A1 (en) 2022-07-22 2024-01-25 F. Hoffmann-La Roche Ag Leukotriene a4 hydrolase (lta4h) as (blood) biomarker for the diagnosis of polycystic ovarian syndrome

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2609390A (en) * 1950-06-01 1952-09-02 Frederick C Bersworth Phosphonic alkylene polyamino acids and method of producing same
US3336221A (en) * 1964-11-05 1967-08-15 Calgon Corp Method of inhibiting precipitation and scale formation
US3331773A (en) * 1966-07-22 1967-07-18 Grace W R & Co Process for inhibiting precipitation in water
US3434969A (en) * 1967-08-11 1969-03-25 Calgon Corp Scale inhibiting
GB1441081A (en) * 1974-01-09 1976-06-30 Ici Ltd Tetra-aza-macrocycles and their metal complexes
US4980148A (en) * 1985-02-06 1990-12-25 Mallinckrodt, Inc. Methods for enhancing magnetic resonance imaging
US4880008A (en) * 1985-05-08 1989-11-14 The General Hospital Corporation Vivo enhancement of NMR relaxivity
US4899755A (en) * 1985-05-08 1990-02-13 The General Hospital Corporation Hepatobiliary NMR contrast agents
DE3825040A1 (de) * 1988-07-20 1990-01-25 Schering Ag, 13353 Berlin 5- oder 6-ring- enthaltende makrocyclische polyaza-verbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
US5247077A (en) * 1989-06-23 1993-09-21 Celltech Limited Tri-aza macrocycles and processes for their preparation
SG46598A1 (en) * 1991-12-10 1998-02-20 Dow Chemical Co Bicycloazamacroyclophosphonic acid conjugates contrast agents and preparation
AU3275293A (en) * 1991-12-10 1993-07-19 Dow Chemical Company, The Bicyclopolyazamacrocyclocarboxylic acid complexes, their conjugates processes for their preparation, and use as radiopharmaceuticals
WO1993011800A1 (en) * 1991-12-10 1993-06-24 The Dow Chemical Company Bicycle-polyazamacrocyclocarboxylic acid complexes, conjugates, preparation and use as contrast agents
US5428139A (en) * 1991-12-10 1995-06-27 The Dow Chemical Company Bicyclopolyazamacrocyclophosphonic acid complexes for use as radiopharmaceuticals

Also Published As

Publication number Publication date
NO954441D0 (no) 1995-11-06
JPH08511003A (ja) 1996-11-19
US5385893A (en) 1995-01-31
FI955336A0 (fi) 1995-11-06
WO1994026276A1 (en) 1994-11-24
HU9502023D0 (en) 1995-09-28
EP0697872B1 (en) 2006-01-25
FI955336A (fi) 1995-12-22
AU6784994A (en) 1994-12-12
SG46496A1 (en) 1998-02-20
EP0697872A4 (en) 2003-04-02
EP0697872A1 (en) 1996-02-28
HUT72649A (en) 1996-05-28
AU687400B2 (en) 1998-02-26
BG100194A (en) 1996-12-31
DE69434618D1 (de) 2006-04-13
PL311649A1 (en) 1996-03-04
NO954441L (no) 1996-01-05
CA2162172A1 (en) 1994-11-24
JP3553940B2 (ja) 2004-08-11
KR960702462A (ko) 1996-04-27
ATE316377T1 (de) 2006-02-15
CN1125906A (zh) 1996-07-03
DE69434618T2 (de) 2006-08-10
LV11429B (en) 1997-04-20

Similar Documents

Publication Publication Date Title
LV11429A (lv) Triciklopoliazamakrociklofosfonskabes to kompleksi un atvasinajumi izmantosanai par kontrastvielam
LV11430A (lv) 2-Piridilmetilenpoliazamakrociklofosfonskabes to kompleksi un atvasinajumi izmantosanai par kontrastvielam
AU2054097A (en) Polyazamacrocyclofluoromonoalkylphosphonic acids, and their complexes, for use as contrast agents
BR9707053B1 (pt) compostos contendo perfluoralquila e composiÇço farmacÊutica.
GR3026658T3 (en) Hydrazino-type radionuclide chelators having an n 3?s configuration
AU4299496A (en) Novel multiple-substituent dtpa derivatives and metal complexes thereof, pharmaceutical compositions containing such complexes, their use in diagnosis and therapy, methods ofpreparing the complexing agents and complexes and methods of preparing the pharmaceutical compositions
AU628095B2 (en) Chelants possessing ortho ligating functionality and complexes thereof
MX9301083A (es) Complejos de quelato y procesos para su preparacion.
DE69223504D1 (de) Bicycloazamakrocyclophosphon-Säure, Komplexe, Konjugate, Kontrastmittel und Herstellung
EP1038524A4 (en) L-THREONATE IRON, PHARMACEUTICAL COMPOSITION AND USE FOR IMPROVEMENT AND TREATMENT OF ANEMIA IN PEOPLE
MY141501A (en) Bicyclopolyazamacrocyclophosphonic acids, their complexes and conjugates, for use as contrast agents and processes for their preparation